Delcath Systems, Inc (DCTH)

Etorro trading 970x250
Delcath Systems, Inc (DCTH) Logo

About Delcath Systems, Inc

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company’s lead product candidate is the melphalan hydrochloride for injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. Its Phase III clinical trial products include FOCUS Trial for the patients with hepatic dominant ocular melanoma; and ALIGN Trial for intrahepatic cholangiocarcinoma. The company also offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York. Address: 1633 Broadway, New York, NY, United States, 10019

Delcath Systems, Inc News and around…

Latest news about Delcath Systems, Inc (DCTH) common stock and company :

Delcath Systems to Present at the H.C. Wainwright BioConnect Virtual Investor Conference on January 10, 2022
07 Jan, 2022 Yahoo! Finance

NEW YORK, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will participate in an upcoming virtual investor conference: H.C. Wainwright BioConnect Virtual Investor Conference January 10-13, 2022 Presentation Date and Time: On-demand beginning January 10, 2022 at 7:00 AM (ET)Webcast: https://journey.ct.events/view/f57806c5-e3e7-4120-85c6-37ab9b15d12

Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
10 Dec, 2021 FinancialContent

Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:ARNC) was changed from Neutral to Overweight. ...

54 Biggest Movers From Yesterday
08 Dec, 2021 FinancialContent

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million ...

36 Stocks Moving In Tuesday's Mid-Day Session
07 Dec, 2021 FinancialContent

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares climbed 123.2% to $6.16. Siyata Mobile received $1.3 million purchase order for ...

3 Stocks Insiders Are Buying
07 Dec, 2021 FinancialContent

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. ...

61 Biggest Movers From Yesterday
03 Dec, 2021 FinancialContent

Gainers Jowell Global Ltd.(NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration ...

Delcath Systems Reveals Initial Survival Data From Ocular Melanoma Trial
02 Dec, 2021 FinancialContent

Delcath Systems Inc(NASDAQ: DCTH) hasannounced results from the Phase 3 FOCUS studyof Hepzato Kit (melphalan ...

40 Stocks Moving In Thursday's Mid-Day Session
02 Dec, 2021 FinancialContent

Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled ...

Delcath Systems, Inc. Announces Positive Phase 3 FOCUS Trial Results for Hepzato™ in Liver-Dominant Metastatic Ocular Melanoma, Including Initial Survival Data Analysis
02 Dec, 2021 Yahoo! Finance

On final analysis of the primary overall response (ORR) endpoint, HEPZATO further exceeded the predefined threshold for success with a median duration of response of 14 months While overall survival data continues to mature, a Hazard Ratio (HR) analysis of survival at 12-months yielded a statistically significant advantage for HEPZATO over a Best Alternative Care (BAC) arm [HR=0.37, p=0.01] in patients who received one or more treatments HEPZATO had statistically significant improvements over BA

The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
02 Dec, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy ...

Delcath Systems Provides Speaker List for Dec 2, 2021 Investor Update Meeting
30 Nov, 2021 Yahoo! Finance

Focus Trial Data and Future Development Plans to be Discussed by Management and KOLsNEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today its agenda and distinguished speaker list for a comprehensive Investor Update Meeting taking place Thursday, December 2nd , from 10:00am ET – 1:30pm EST. The event will focus on the company’s US product candida

Is Delcath Systems (NASDAQ:DCTH) Weighed On By Its Debt Load?
11 Nov, 2021 Yahoo! Finance

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Recap: Delcath Systems Q3 Earnings
09 Nov, 2021 FinancialContent

Delcath Systems (NASDAQ:DCTH) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM. Here's what ...

Delcath Systems Announces Third Quarter 2021 Results
09 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today reported business highlights and financial results for the third quarter ended September 30, 2021. Recent Business Highlights During and since the third quarter Delcath: Entered a debt facility with Avenue Venture Opportunities Fund, L.P. providing up to $20 million with an initial $15 million fund

Delcath Systems, Inc. (DCTH) Stock Jumps 6.6%: Will It Continue to Soar?
08 Nov, 2021 Yahoo! Finance

Delcath Systems, Inc. (DCTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Delcath Systems to Participate in the Canaccord Virtual MedTech, Diagnostics and Digital Health & Services Forum on November 18, 2021
08 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today it will participate in an upcoming virtual investor conference: Canaccord Virtual MedTech, Diagnostics and Digital Health & Services Forum Thursday, November 18, 2021: 1x1 meetings only To learn more or to schedule a one-on-one meeting with management, please contact your conference repr

Delcath Systems to Hold Investor Update on Focus Trial Data and Future Development Plans on December 2, 2021
05 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a comprehensive Investor Update event on Thursday, December 2nd, from 10:00am ET – 1:00pm ET. The event will feature physicians discussing percutaneous hepatic perfusion, updated Focus trial data and the role of Hepzato™ Kit (melphalan hydrochloride for injection/Hepatic Delivery

Will Delcath Systems, Inc. (DCTH) Report Negative Earnings Next Week? What You Should Know
02 Nov, 2021 Yahoo! Finance

Delcath Systems, Inc. (DCTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Delcath Systems Schedules Conference Call to Report 2021 Third Quarter Financial Results
25 Oct, 2021 Yahoo! Finance

NEW YORK, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today it will host a conference call on Nov 9, 2021 at 8:30 AM Eastern Time to discuss results for its third quarter ended September 30, 2021. Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Date: November 9, 2021Tim

Delcath Systems to Present at Upcoming Virtual Investor Conferences
02 Sep, 2021 FinancialContent
Delcath Systems: Q2 Earnings Insights
10 Aug, 2021 FinancialContent

Shares of Delcath Systems (NASDAQ:DCTH) fell 13.6% in pre-market trading after the company reported Q2 results. Quarterly ...

Delcath Systems Announces Second Quarter 2021 Results
10 Aug, 2021 FinancialContent
Earnings Scheduled For August 10, 2021
10 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its ...

Earnings Preview For Delcath Systems
09 Aug, 2021 FinancialContent

Delcath Systems (NASDAQ:DCTH) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's everything-that-matters ...

Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
09 Aug, 2021 FinancialContent
CytRx Announces Director Election Results from 2021 Annual Meeting of Stockholders
29 Jul, 2021 FinancialContent

CytRx Corporation (OTCQB: CYTR) ("CytRx" or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today announced that based on results from its 2021 Annual Meeting of Stockholders (the "Annual Meeting"), both of the Company’s Class III director candidates – Joel K. Caldwell, CPA and Jennifer K. Simpson, Ph.D. – have been elected to the Board of Directors (the "Board"). Additional information pertaining to the Company’s Annual Meeting results can be found on the Form 8-K filed with the U.S. Securities and Exchange Commission.

Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results
28 Jul, 2021 FinancialContent
12 Health Care Stocks Moving In Friday's After-Market Session
09 Jul, 2021 FinancialContent

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded ...

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
08 Jul, 2021 Yahoo! Finance

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th \- 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event.

Delcath Systems to Present at Access to Giving Virtual Conference on July 13, 2021 at 3 p.m. ET
07 Jul, 2021 FinancialContent

Delcath Systems, Inc (DCTH) is a NASDAQ Common Stock listed in , ,

970x250